Skip to main content

Web-Based Cognitive Behavioral Therapy Aids Bulimia Outcomes

Medically reviewed by Carmen Pope, BPharm. Last updated on July 19, 2024.

By Lori Solomon HealthDay Reporter

THURSDAY, July 18, 2024 -- A web-based, cognitive behavioral self-help intervention effectively cuts bulimia nervosa symptoms, according to a study published online July 3 in JAMA Network Open.

Steffen Hartmann, from Heidelberg University in Germany, and colleagues evaluated the effectiveness of a web-based cognitive behavioral self-help intervention for individuals with bulimia nervosa. Adult patients with bulimia nervosa (154 participants; ages 19 to 65 years) were randomly assigned to 12 weekly modules or a wait-list control.

The researchers found that participants receiving the web-based intervention showed a significantly greater decrease in bulimic episodes versus the control group, representing a significant change in binge-eating episodes. However, there was no significant improvement seen in compensatory behaviors. Benefits of the intervention were also seen for improvement in global eating disorder symptoms and clinical impairment. Well-being and work capacity did not show improvement with the intervention.

"These findings underscore the effectiveness of web-based cognitive behavioral treatments for bulimia nervosa and suggest that these interventions can complement face-to-face therapies," the authors write. "Building on these results, future research should test whether more extensive interventions (i.e., blended or ecological momentary interventions) can impact compensatory behaviors, comorbid symptoms, and overall well-being more effectively."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Benzodiazepines Not Tied to Higher Dementia Risk in Older Adults

TUESDAY, July 16, 2024 -- Use of benzodiazepines is not associated with increased dementia risk in older adults, according to a study published online July 2 in BMC...

Metformin, SGLT2 Inhibitors Exhibit Significantly Lower Dementia Risk

MONDAY, July 15, 2024 -- Compared with other antidiabetic classes, metformin and sodium glucose co-transporter-2 inhibitors (SGLT2is) exhibit significantly lower dementia risk...

Nightmares in Midlife May Point to Future Cognitive Decline, Dementia

FRIDAY, July 12, 2024 -- Distressing dreams in middle-aged and older adults may indicate a higher risk for future cognitive decline and all-cause dementia, according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.